Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial
Publication year
2024Author(s)
Source
Nature Communications, 15, 1, (2024), pp. 1-10, article 1632ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Medical Oncology
Medical Biosciences
Pharmacy
Medical Imaging
Dermatology
Haematology
Data Science
Surgery
Journal title
Nature Communications
Volume
vol. 15
Issue
iss. 1
Page start
p. 1
Page end
p. 10
Subject
Data Science; Dermatology - Radboud University Medical Center; Haematology - Radboud University Medical Center; Medical Biosciences - Radboud University Medical Center; Medical Imaging - Radboud University Medical Center; Medical Oncology - Radboud University Medical Center; Pharmacy - Radboud University Medical Center; Surgery - Radboud University Medical CenterThis item appears in the following Collection(s)
- Academic publications [246515]
- Electronic publications [134102]
- Faculty of Medical Sciences [93308]
- Faculty of Science [38028]
- Open Access publications [107627]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.